JeffreyBradfordLowMDMBA
Other MD/DO • San Francisco, CAPrincipal, Novo Growth | Life Sciences Investor
Dr. Low is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
501 2nd Street
#300
San Francisco, CA 94107
Clinical Expertise
- Venture Capital
Education & Training
Yale School of MedicineClass of 2015
Harvard Business SchoolMBA- Harvard UniversityAB, Molecular and Cellular Biology
Awards, Honors, & Recognition
- Forbes 30 under 30 in Venture Capital Forbes, 2019
Publications & Presentations
PubMed
- 12 citationsComparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project.Jeffrey B. Low, Joseph S. Ross, Jessica D. Ritchie, Cary P. Gross, Richard Lehman
Systematic Reviews. 2017-02-15 - 1 citationsMoving forward from rhBMP-2: open science and data sharing.Jeffrey B. Low, Joseph S. Ross, Harlan M. Krumholz
Spine. 2014-04-01 - 63 citationsComplications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine.Jesse Chrastil, Jeffrey B. Low, Peter G. Whang, Alpesh A. Patel
Spine. 2013-07-15
Press Mentions
30 Under 30 Venture Capital 2019: These Up-and-Coming Investors Are Changing the Face of VCNovember 14th, 2018
External Links
- Websitehttp://jeffreylow.com
- a16z articleshttps://a16z.com/author/jeffrey-low/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
